Clients News • MC Services corporate website
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive




  • InflaRx to Present at Upcoming Virtual Investor Events
  • Andera Partners’ Portfolio Company T-knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
  • Secarna Pharmaceuticals and Evotec form strategic partnership in the field of antisense therapy
  • CENTOGENE unterstützt Tadschikistan im Kampf gegen die COVID-19-Pandemie
  • CENTOGENE bietet ab sofort die für Einreisende kostenlosen, freiwilligen Tests in Walk-In-Testzentren am Frankfurter Flughafen an
  • Adocia initiates BioChaperone® Lispro comparative study to validate THDB insulin lispro for Phase 3 BC Lispro trials in Europe and U.S.
  • InflaRx Reports Q2 2020 Financial & Operating Results
  • Apogenix to Start European Clinical Phase II Trial with Asunercept in COVID-19 Patients
  • GBA Group Pharma: GBA Group Pharma updates on clinical trial risks following Brexit
  • Imcyse SA: Imcyse Awarded Subsidy from the Walloon Region for Neuromyelitis Optica Spectrum Disorder Study